Bausch Health Companies (BHC) Change in Accured Expenses (2009 - 2026)

Bausch Health Companies (BHC) has 18 years of Change in Accured Expenses data on file, last reported at -$150.0 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 51.52% year-over-year to -$150.0 million; the trailing twelve-month figure through Mar 2026 stood at -$127.0 million (down 161.35% YoY), and the FY2025 full-year result was -$76.0 million, down 121.29% from the prior year.
• Change in Accured Expenses improved to -$150.0 million in Q1 2026, from -$284.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $166.0 million in Q3 2023 to a low of -$284.0 million in Q4 2025.
• A 5-year average of $12.6 million and a median of $47.0 million in 2022 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 737.5% in 2024 and tumbled 1283.33% in 2025, its largest moves.
• Tracing BHC's Change in Accured Expenses over 5 years: stood at $47.0 million in 2022, then jumped by 106.38% to $97.0 million in 2023, then slumped by 75.26% to $24.0 million in 2024, then plunged by 1283.33% to -$284.0 million in 2025, then soared by 47.18% to -$150.0 million in 2026.
• Business Quant data shows BHC's Change in Accured Expenses at -$150.0 million in Q1 2026, -$284.0 million in Q4 2025, and $144.0 million in Q3 2025.